4//SEC Filing
Garner Thomas 4
Accession 0001415889-24-028884
CIK 0001070494other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 6:33 PM ET
Size
8.0 KB
Accession
0001415889-24-028884
Insider Transaction Report
Form 4
Garner Thomas
EVP, Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2024-12-09+45,372→ 45,372 total→ Common Stock (45,372 underlying) - Award
Stock Option (Right to Buy)
2024-12-09+235,849→ 235,849 totalExercise: $18.76Exp: 2034-12-08→ Common Stock (235,849 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the Stock Option granted under the 2024 Equity Incentive Plan (the "Plan") will vest and become exercisable on December 9, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit granted under the Plan represents a contingent right to receive one share of the Issuer's common stock.
- [F3]50% of the restricted stock units vest on December 9, 2026 and 25% vest on each of December 9, 2027 and December 9, 2028.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001996325
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 6:33 PM ET
- Size
- 8.0 KB